GAL3ST1: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Galactosylceramide sulfotransferase''' is an [[enzyme]] that in humans is encoded by the ''GAL3ST1'' [[gene]].<ref name="pmid9847074">{{cite journal | title = Toward a complete human genome sequence | journal = Genome Res | volume = 8 | issue = 11 | pages = 1097–108 |date=Jan 1999 | pmid = 9847074 | pmc = | doi = 10.1101/gr.8.11.1097}}</ref><ref name="pmid9030544">{{cite journal |vauthors=Honke K, Tsuda M, Hirahara Y, Ishii A, Makita A, Wada Y | title = Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase | journal = J Biol Chem | volume = 272 | issue = 8 | pages = 4864–8 |date=Apr 1997 | pmid = 9030544 | pmc = | doi =10.1074/jbc.272.8.4864 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: GAL3ST1 galactose-3-O-sulfotransferase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9514| accessdate = }}</ref> | ||
}} | |||
{{ | |||
| | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. The product of this gene is galactosylceramide sulfotransferase which catalyzes the conversion between 3'-phosphoadenylylsulfate + a galactosylceramide to adenosine 3',5'-bisphosphate + galactosylceramide sulfate. Activity of this sulfotransferase is enhanced in renal cell carcinoma.<ref name="entrez" | | summary_text = Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. The product of this gene is galactosylceramide sulfotransferase which catalyzes the conversion between 3'-phosphoadenylylsulfate + a galactosylceramide to adenosine 3',5'-bisphosphate + galactosylceramide sulfate. Activity of this sulfotransferase is enhanced in renal cell carcinoma.<ref name="entrez"/> | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | author=Siegrist HP | *{{cite journal | author=Siegrist HP |title=Age-dependent modulation of 3'-phosphoadenosine-5'-phosphosulfate-galactosylceramide sulfotransferase by lipids extracted from the microsomal membranes and artificial lipid mixtures |journal=Biochim. Biophys. Acta |volume=489 |issue= 1 |pages= 58–63 |year= 1977 |pmid= 911873 |doi= 10.1016/0005-2760(77)90231-4|name-list-format=vanc| author2=Jutzi H | author3=Steck AJ | display-authors=3 | last4=Burkart | first4=T | last5=Wiesmann | first5=U | last6=Herschkowitz | first6=N }} | ||
*{{cite journal | author=Stein C | *{{cite journal | author=Stein C |title=Cloning and expression of human arylsulfatase A |journal=J. Biol. Chem. |volume=264 |issue= 2 |pages= 1252–9 |year= 1989 |pmid= 2562955 |doi= |name-list-format=vanc| author2=Gieselmann V | author3=Kreysing J | display-authors=3 | last4=Schmidt | first4=B | last5=Pohlmann | first5=R | last6=Waheed | first6=A | last7=Meyer | first7=HE | last8=O'Brien | first8=JS | last9=Von Figura | first9=K }} | ||
*{{cite journal | | *{{cite journal |vauthors=Fleischer B, Zambrano F |title=Localization of cerebroside-sulfotransferase activity in the Golgi apparatus of rat kidney |journal=Biochem. Biophys. Res. Commun. |volume=52 |issue= 3 |pages= 951–8 |year= 1973 |pmid= 4710574 |doi=10.1016/0006-291X(73)91029-2 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Farrell DF, McKhann GM |title=Characterization of cerebroside sulfotransferase from rat brain |journal=J. Biol. Chem. |volume=246 |issue= 15 |pages= 4694–702 |year= 1971 |pmid= 5562350 |doi= }} | ||
*{{cite journal | author=Costantino-Ceccarini E | *{{cite journal | author=Costantino-Ceccarini E |title=Distribution of lipid synthesizing enzymes, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin proteins in rat forebrain subfractions during development |journal=Neurochem. Res. |volume=7 |issue= 1 |pages= 1–12 |year= 1982 |pmid= 6280086 |doi=10.1007/BF00965064 |name-list-format=vanc| author2=Waehneldt TV | author3=Ginalski H | display-authors=3 | last4=Burgisser | first4=Philippe | last5=Reigner | first5=Jacqueline | last6=Matthieu | first6=Jean-Marie }} | ||
*{{cite journal | | *{{cite journal |vauthors=Benjamins JA, Hadden T, Skoff RP |title=Cerebroside sulfotransferase in Golgi-enriched fractions from rat brain |journal=J. Neurochem. |volume=38 |issue= 1 |pages= 233–41 |year= 1982 |pmid= 6955451 |doi=10.1111/j.1471-4159.1982.tb10875.x }} | ||
*{{cite journal | author=Honke K | *{{cite journal | author=Honke K |title=Purification and characterization of 3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase from human renal cancer cells |journal=J. Biochem. |volume=119 |issue= 3 |pages= 421–7 |year= 1996 |pmid= 8830034 |doi= 10.1093/oxfordjournals.jbchem.a021258|name-list-format=vanc| author2=Yamane M | author3=Ishii A | display-authors=3 | last4=Kobayashi | first4=T | last5=Makita | first5=A }} | ||
*{{cite journal | author=Tsuda M |title=Cancer-associated alternative usage of multiple promoters of human GalCer sulfotransferase gene |journal=Eur. J. Biochem. |volume=267 |issue= 9 |pages= 2672–9 |year= 2000 |pmid= 10785389 |doi=10.1046/j.1432-1327.2000.01281.x |name-list-format=vanc| author2=Egashira M | author3=Niikawa N | display-authors=3 | last4=Wada | first4=Yoshinao | last5=Honke | first5=Koichi }} | |||
*{{cite journal |vauthors=Eckhardt M, Fewou SN, Ackermann I, Gieselmann V |title=N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase |journal=Biochem. J. |volume=368 |issue= Pt 1 |pages= 317–24 |year= 2002 |pmid= 12175333 |doi= 10.1042/BJ20020946 | pmc=1222978 }} | |||
*{{cite journal | author=Tsuda M | *{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |name-list-format=vanc| author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} | ||
*{{cite journal | | *{{cite journal | author=Collins JE |title=A genome annotation-driven approach to cloning the human ORFeome |journal=Genome Biol. |volume=5 |issue= 10 |pages= R84 |year= 2005 |pmid= 15461802 |doi= 10.1186/gb-2004-5-10-r84 | pmc=545604 |name-list-format=vanc| author2=Wright CL | author3=Edwards CA | display-authors=3 | last4=Davis | first4=Matthew P | last5=Grinham | first5=James A | last6=Cole | first6=Charlotte G | last7=Goward | first7=Melanie E | last8=Aguado | first8=Begoña | last9=Mallya | first9=Meera }} | ||
*{{cite journal | author=Strausberg RL | *{{cite journal | author=Gerhard DS |title=The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |name-list-format=vanc| author2=Wagner L | author3=Feingold EA | display-authors=3 | last4=Shenmen | first4=CM | last5=Grouse | first5=LH | last6=Schuler | first6=G | last7=Klein | first7=SL | last8=Old | first8=S | last9=Rasooly | first9=R }} | ||
*{{cite journal | author=Collins JE | |||
*{{cite journal | author=Gerhard DS | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-22-stub}} | {{gene-22-stub}} | ||
Latest revision as of 08:37, 31 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Galactosylceramide sulfotransferase is an enzyme that in humans is encoded by the GAL3ST1 gene.[1][2][3]
Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. The product of this gene is galactosylceramide sulfotransferase which catalyzes the conversion between 3'-phosphoadenylylsulfate + a galactosylceramide to adenosine 3',5'-bisphosphate + galactosylceramide sulfate. Activity of this sulfotransferase is enhanced in renal cell carcinoma.[3]
References
- ↑ "Toward a complete human genome sequence". Genome Res. 8 (11): 1097–108. Jan 1999. doi:10.1101/gr.8.11.1097. PMID 9847074.
- ↑ Honke K, Tsuda M, Hirahara Y, Ishii A, Makita A, Wada Y (Apr 1997). "Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase". J Biol Chem. 272 (8): 4864–8. doi:10.1074/jbc.272.8.4864. PMID 9030544.
- ↑ 3.0 3.1 "Entrez Gene: GAL3ST1 galactose-3-O-sulfotransferase 1".
Further reading
- Siegrist HP, Jutzi H, Steck AJ, et al. (1977). "Age-dependent modulation of 3'-phosphoadenosine-5'-phosphosulfate-galactosylceramide sulfotransferase by lipids extracted from the microsomal membranes and artificial lipid mixtures". Biochim. Biophys. Acta. 489 (1): 58–63. doi:10.1016/0005-2760(77)90231-4. PMID 911873.
- Stein C, Gieselmann V, Kreysing J, et al. (1989). "Cloning and expression of human arylsulfatase A". J. Biol. Chem. 264 (2): 1252–9. PMID 2562955.
- Fleischer B, Zambrano F (1973). "Localization of cerebroside-sulfotransferase activity in the Golgi apparatus of rat kidney". Biochem. Biophys. Res. Commun. 52 (3): 951–8. doi:10.1016/0006-291X(73)91029-2. PMID 4710574.
- Farrell DF, McKhann GM (1971). "Characterization of cerebroside sulfotransferase from rat brain". J. Biol. Chem. 246 (15): 4694–702. PMID 5562350.
- Costantino-Ceccarini E, Waehneldt TV, Ginalski H, et al. (1982). "Distribution of lipid synthesizing enzymes, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin proteins in rat forebrain subfractions during development". Neurochem. Res. 7 (1): 1–12. doi:10.1007/BF00965064. PMID 6280086.
- Benjamins JA, Hadden T, Skoff RP (1982). "Cerebroside sulfotransferase in Golgi-enriched fractions from rat brain". J. Neurochem. 38 (1): 233–41. doi:10.1111/j.1471-4159.1982.tb10875.x. PMID 6955451.
- Honke K, Yamane M, Ishii A, et al. (1996). "Purification and characterization of 3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase from human renal cancer cells". J. Biochem. 119 (3): 421–7. doi:10.1093/oxfordjournals.jbchem.a021258. PMID 8830034.
- Tsuda M, Egashira M, Niikawa N, et al. (2000). "Cancer-associated alternative usage of multiple promoters of human GalCer sulfotransferase gene". Eur. J. Biochem. 267 (9): 2672–9. doi:10.1046/j.1432-1327.2000.01281.x. PMID 10785389.
- Eckhardt M, Fewou SN, Ackermann I, Gieselmann V (2002). "N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase". Biochem. J. 368 (Pt 1): 317–24. doi:10.1042/BJ20020946. PMC 1222978. PMID 12175333.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome". Genome Biol. 5 (10): R84. doi:10.1186/gb-2004-5-10-r84. PMC 545604. PMID 15461802.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
![]() | This article on a gene on human chromosome 22 is a stub. You can help Wikipedia by expanding it. |